On June 11, 2025, the UW Initiative to End Alzheimer’s (IEA) hosted the Alzheimer’s Ends Here luncheon, an inspiring fundraiser in support of advancing research programs at the University of Wisconsin–Madison. The inaugural program brought together researchers, faculty and staff, IEA board members and friends united by a common goal: to end Alzheimer’s disease.
Claire Bitner
Companies announce findings about potential new Alzheimer’s drug lecanemab
Dr. Cynthia Carlsson, MD, MS spoke to multiple media outlets about the news, sharing information about a current UW study investigating use of lecanemab.
Improving access to Alzheimer’s disease services for Latinos
Dr. Mora Pinzon’s work and research centers on improving access to Alzheimer’s disease and related dementia services within the Latino community.